Year |
Citation |
Score |
2011 |
Muftuoglu Y, Mustata G. Aromatase inhibitors and antiepileptic drugs: a computational systems biology analysis. Reproductive Biology and Endocrinology : Rb&E. 9: 92. PMID 21693043 DOI: 10.1186/1477-7827-9-92 |
0.336 |
|
2011 |
Mustata G, Li M, Zevola N, Bakan A, Zhang L, Epperly M, Greenberger JS, Yu J, Bahar I. Development of small-molecule PUMA inhibitors for mitigating radiation-induced cell death. Current Topics in Medicinal Chemistry. 11: 281-90. PMID 21320058 DOI: 10.2174/156802611794072641 |
0.314 |
|
2011 |
Meireles LM, Mustata G. Discovery of modulators of protein-protein interactions: current approaches and limitations. Current Topics in Medicinal Chemistry. 11: 248-57. PMID 21320056 DOI: 10.2174/156802611794072632 |
0.337 |
|
2011 |
Mustata G. The protein-protein interactions as a target in medicinal chemistry and drug discovery. Current Topics in Medicinal Chemistry. 11: 247. PMID 21320055 DOI: 10.2174/156802611794072597 |
0.305 |
|
2010 |
Muftuoglu Y, Mustata G. Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19). Bioorganic & Medicinal Chemistry Letters. 20: 3050-64. PMID 20413308 DOI: 10.1016/J.Bmcl.2010.03.113 |
0.416 |
|
2010 |
Sharlow ER, Lyda TA, Dodson HC, Mustata G, Morris MT, Leimgruber SS, Lee KH, Kashiwada Y, Close D, Lazo JS, Morris JC. A target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activity. Plos Neglected Tropical Diseases. 4: e659. PMID 20405000 DOI: 10.1371/Journal.Pntd.0000659 |
0.361 |
|
2010 |
Muftuoglu Y, Mustata G. Erratum to “Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19)” [Bioorg. Med. Chem. Lett. 20 (2010) 3050] Bioorganic & Medicinal Chemistry Letters. 20: 4955-4959. DOI: 10.1016/J.Bmcl.2010.06.115 |
0.319 |
|
2009 |
Sharlow ER, Close D, Shun T, Leimgruber S, Reed R, Mustata G, Wipf P, Johnson J, O'Neil M, Grögl M, Magill AJ, Lazo JS. Identification of potent chemotypes targeting Leishmania major using a high-throughput, low-stringency, computationally enhanced, small molecule screen. Plos Neglected Tropical Diseases. 3: e540. PMID 19888337 DOI: 10.1371/Journal.Pntd.0000540 |
0.363 |
|
2009 |
Mustata G, Follis AV, Hammoudeh DI, Metallo SJ, Wang H, Prochownik EV, Lazo JS, Bahar I. Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model. Journal of Medicinal Chemistry. 52: 1247-50. PMID 19215087 DOI: 10.1021/Jm801278G |
0.353 |
|
2006 |
Mustata G, Dinh SM. Approaches to oral drug delivery for challenging molecules. Critical Reviews in Therapeutic Drug Carrier Systems. 23: 111-35. PMID 16952274 DOI: 10.1615/Critrevtherdrugcarriersyst.V23.I2.20 |
0.342 |
|
2005 |
Brigo A, Mustata GI, Briggs JM, Moro S. Discovery of HIV-1 integrase inhibitors through a novel combination of ligand and structure-based drug design. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 1: 263-75. PMID 16787322 DOI: 10.2174/1573406053765440 |
0.584 |
|
2005 |
Brigo A, Lee KW, Fogolari F, Mustata GI, Briggs JM. Comparative molecular dynamics simulations of HIV-1 integrase and the T66I/M154I mutant: binding modes and drug resistance to a diketo acid inhibitor. Proteins. 59: 723-41. PMID 15815973 DOI: 10.1002/Prot.20447 |
0.569 |
|
2004 |
Mustata G, Briggs JM. Cluster analysis of water molecules in alanine racemase and their putative structural role. Protein Engineering, Design & Selection : Peds. 17: 223-34. PMID 15115851 DOI: 10.1093/Protein/Gzh033 |
0.515 |
|
2004 |
Mustata GI, Brigo A, Briggs JM. HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors. Bioorganic & Medicinal Chemistry Letters. 14: 1447-54. PMID 15006380 DOI: 10.1016/J.Bmcl.2004.01.027 |
0.536 |
|
2003 |
Mustata GI, Soares TA, Briggs JM. Molecular dynamics studies of alanine racemase: a structural model for drug design. Biopolymers. 70: 186-200. PMID 14517907 DOI: 10.1002/Bip.10425 |
0.587 |
|
2002 |
Mustata GI, Briggs JM. A structure-based design approach for the identification of novel inhibitors: application to an alanine racemase. Journal of Computer-Aided Molecular Design. 16: 935-53. PMID 12825624 DOI: 10.1023/A:1023875514454 |
0.587 |
|
2002 |
Crossnoe CR, Germanas JP, LeMagueres P, Mustata G, Krause KL. The crystal structure of Trichomonas vaginalis ferredoxin provides insight into metronidazole activation Journal of Molecular Biology. 318: 503-518. PMID 12051855 DOI: 10.1016/S0022-2836(02)00051-7 |
0.337 |
|
Show low-probability matches. |